150 related articles for article (PubMed ID: 30787992)
1. Protective effects of sodium tanshinone IIA sulfonate on cardiac function after myocardial infarction in mice.
Wu P; Du Y; Xu Z; Zhang S; Liu J; Aa N; Yang Z
Am J Transl Res; 2019; 11(1):351-360. PubMed ID: 30787992
[TBL] [Abstract][Full Text] [Related]
2. Sodium Tanshinone IIA Sulfonate Improves Adverse Ventricular Remodeling Post-MI by Reducing Myocardial Necrosis, Modulating Inflammation, and Promoting Angiogenesis.
Zhang B; Yu P; Su E; Jia J; Zhang C; Xie S; Huang Z; Dong Y; Ding J; Zou Y; Jiang H; Ge J
Curr Pharm Des; 2022; 28(9):751-759. PubMed ID: 34951571
[TBL] [Abstract][Full Text] [Related]
3. Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice.
Gao S; Li L; Li L; Ni J; Guo R; Mao J; Fan G
J Mol Cell Cardiol; 2019 Dec; 137():59-70. PubMed ID: 31629735
[TBL] [Abstract][Full Text] [Related]
4. Exploration of Multiple Signaling Pathways Through Which Sodium Tanshinone IIA Sulfonate Attenuates Pathologic Remodeling Experimental Infarction.
Mao S; Vincent M; Chen M; Zhang M; Hinek A
Front Pharmacol; 2019; 10():779. PubMed ID: 31354493
[TBL] [Abstract][Full Text] [Related]
5. Sodium tanshinone IIA sulfonate attenuates cardiac dysfunction and improves survival of rats with cecal ligation and puncture-induced sepsis.
Meng ZJ; Wang C; Meng LT; Bao BH; Wu JH; Hu YQ
Chin J Nat Med; 2018 Nov; 16(11):846-855. PubMed ID: 30502766
[TBL] [Abstract][Full Text] [Related]
6. Rationale and Design of Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial Infarction (STAMP-REMODELING) Trial: A Randomized Controlled Study.
Mao S; Li X; Wang L; Yang PC; Zhang M
Cardiovasc Drugs Ther; 2015 Dec; 29(6):535-542. PubMed ID: 26482376
[TBL] [Abstract][Full Text] [Related]
7. Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics.
Zhou ZY; Zhao WR; Zhang J; Chen XL; Tang JY
Biomed Pharmacother; 2019 Oct; 118():109362. PubMed ID: 31545252
[TBL] [Abstract][Full Text] [Related]
8. Sodium tanshinone IIA sulfonate ameliorates ischemia-induced myocardial inflammation and lipid accumulation in Beagle dogs through NLRP3 inflammasome.
Hu Q; Wei B; Wei L; Hua K; Yu X; Li H; Ji H
Int J Cardiol; 2015 Oct; 196():183-92. PubMed ID: 26143630
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression.
Ren ZH; Tong YH; Xu W; Ma J; Chen Y
Phytomedicine; 2010 Mar; 17(3-4):212-8. PubMed ID: 19800776
[TBL] [Abstract][Full Text] [Related]
10. Sodium Tanshinone IIA sulfonate improves post-ischemic angiogenesis in hyperglycemia.
Chen L; He W; Peng B; Yuan M; Wang N; Wang J; Lu W; Wang T
Biochem Biophys Res Commun; 2019 Dec; 520(3):580-585. PubMed ID: 31623833
[TBL] [Abstract][Full Text] [Related]
11. Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation.
Yang R; Liu A; Ma X; Li L; Su D; Liu J
J Cardiovasc Pharmacol; 2008 Apr; 51(4):396-401. PubMed ID: 18427283
[TBL] [Abstract][Full Text] [Related]
12. The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia/reperfusion injury in rats.
Wei B; Li WW; Ji J; Hu QH; Ji H
Atherosclerosis; 2014 Aug; 235(2):318-27. PubMed ID: 24911635
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes.
Zhang Y; Zhang L; Chu W; Wang B; Zhang J; Zhao M; Li X; Li B; Lu Y; Yang B; Shan H
Cell Physiol Biochem; 2010; 26(6):991-8. PubMed ID: 21220930
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA protects against heart failure post-myocardial infarction via AMPKs/mTOR-dependent autophagy pathway.
Zhang X; Wang Q; Wang X; Chen X; Shao M; Zhang Q; Guo D; Wu Y; Li C; Wang W; Wang Y
Biomed Pharmacother; 2019 Apr; 112():108599. PubMed ID: 30798134
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1.
Zhu J; Xu Y; Ren G; Hu X; Wang C; Yang Z; Li Z; Mao W; Lu D
Eur J Pharmacol; 2017 Nov; 815():427-436. PubMed ID: 28970012
[TBL] [Abstract][Full Text] [Related]
16. Sodium tanshinone IIA sulfonate ameliorates cerebral ischemic injury through regulation of angiogenesis.
Xu J; Zhang P; Chen Y; Xu Y; Luan P; Zhu Y; Zhang J
Exp Ther Med; 2021 Oct; 22(4):1122. PubMed ID: 34504576
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway.
Mao S; Wang L; Chen P; Lan Y; Guo R; Zhang M
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S707-S716. PubMed ID: 30284484
[TBL] [Abstract][Full Text] [Related]
18. Regulation of antioxidant system, lipids and fatty acid β-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats.
Wei B; You MG; Ling JJ; Wei LL; Wang K; Li WW; Chen T; Du QM; Ji H
Atherosclerosis; 2013 Sep; 230(1):148-56. PubMed ID: 23958267
[TBL] [Abstract][Full Text] [Related]
19. Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study.
Chan SE; Lai HW; Su CC; Kuo SJ; Chien SY; Lin HY; Chen DR
Evid Based Complement Alternat Med; 2011; 2011():841564. PubMed ID: 21716682
[TBL] [Abstract][Full Text] [Related]
20. Mechanism Study of the Protective Effects of Sodium Tanshinone IIA Sulfonate Against Atorvastatin-Induced Cerebral Hemorrhage in Zebrafish: Transcriptome Analysis.
Zhou ZY; Zhao WR; Xiao Y; Zhang J; Tang JY; Lee SM
Front Pharmacol; 2020; 11():551745. PubMed ID: 33123006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
